pirbuterol has been researched along with Coronary Disease in 3 studies
pirbuterol: structure
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pirbuterol hydrochloride, an orally effective beta-adrenergic agonist, improves hemodynamic abnormalities in patients with congestive heart failure, but its effects on myocardial oxygen consumption (MVO2) and coronary blood flow have not been characterized." | 7.66 | Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure. ( Brown, EJ; Colucci, WS; Grossman, W; Lorell, BH; Mudge, GH; Rude, RE; Taylor, CR; Turi, Z, 1981) |
| "Pirbuterol hydrochloride, an orally effective beta-adrenergic agonist, improves hemodynamic abnormalities in patients with congestive heart failure, but its effects on myocardial oxygen consumption (MVO2) and coronary blood flow have not been characterized." | 3.66 | Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure. ( Brown, EJ; Colucci, WS; Grossman, W; Lorell, BH; Mudge, GH; Rude, RE; Taylor, CR; Turi, Z, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nelson, GI | 1 |
| Silke, B | 1 |
| Barker, MC | 1 |
| Saxton, CA | 1 |
| Taylor, SH | 1 |
| Smiseth, OA | 1 |
| Rude, RE | 1 |
| Turi, Z | 1 |
| Brown, EJ | 1 |
| Lorell, BH | 1 |
| Colucci, WS | 1 |
| Mudge, GH | 1 |
| Taylor, CR | 1 |
| Grossman, W | 1 |
3 other studies available for pirbuterol and Coronary Disease
| Article | Year |
|---|---|
A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
Topics: Adrenergic beta-Agonists; Blood Pressure; Cardiac Output; Coronary Disease; Dose-Response Relationsh | 1982 |
Effects of the beta-adrenergic receptor agonist pirbuterol on cardiac performance during acute ischaemic left ventricular failure in dogs.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Coronary Disease; Dogs; Ethanolamines; Fatty Acid | 1983 |
Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Coronary Disease; Ethanolamines; Heart | 1981 |